Fresenius SE & Co. KGaA (FSNUY)
FSNUY Stock Price Chart
Explore Fresenius SE & Co. KGaA interactive price chart. Choose custom timeframes to analyze FSNUY price movements and trends.
FSNUY Company Profile
Discover essential business fundamentals and corporate details for Fresenius SE & Co. KGaA (FSNUY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
15 May 2012
Employees
175.20K
Website
https://www.fresenius.comCEO
Michael Sen
Description
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
FSNUY Financial Timeline
Browse a chronological timeline of Fresenius SE & Co. KGaA corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Nov 2025
Earnings released on 6 Aug 2025
EPS came in at $0.24 surpassing the estimated $0.22 by +9.99%, while revenue for the quarter reached $6.57B , beating expectations by +13.12%.
Earnings released on 7 May 2025
EPS came in at $0.23 surpassing the estimated $0.21 by +9.89%, while revenue for the quarter reached $6.19B , beating expectations by +14.50%.
Dividend declared on 10 Apr 2025
A dividend of $0.28 per share was announced, adjusted to $0.28. The dividend was paid on 4 Jun 2025.
Earnings released on 26 Feb 2025
EPS came in at $0.18 falling short of the estimated $0.18 by -0.55%, while revenue for the quarter reached $5.83B , beating expectations by +4.39%.
Earnings released on 6 Nov 2024
EPS came in at $0.19 surpassing the estimated $0.18 by +7.53%, while revenue for the quarter reached $5.89B , beating expectations by +3.81%.
Earnings released on 31 Jul 2024
EPS came in at $0.22 surpassing the estimated $0.19 by +15.55%, while revenue for the quarter reached $5.87B , beating expectations by +0.75%.
Earnings released on 8 May 2024
EPS came in at $0.20 surpassing the estimated $0.19 by +5.88%, while revenue for the quarter reached $5.75B , missing expectations by -6.12%.
Earnings released on 19 Mar 2024
EPS came in at -$1.20 falling short of the estimated $0.20 by -698.54%, while revenue for the quarter reached $6.24B , missing expectations by -14.70%.
Earnings released on 2 Nov 2023
EPS came in at $0.17 surpassing the estimated $0.16 by +3.60%, while revenue for the quarter reached $5.82B , missing expectations by -48.93%.
Earnings released on 2 Aug 2023
EPS came in at $0.18 surpassing the estimated $0.18 by +2.86%, while revenue for the quarter reached $11.30B , missing expectations by -0.24%.
Earnings released on 9 May 2023
EPS came in at $0.19 surpassing the estimated $0.17 by +13.10%, while revenue for the quarter reached $11.12B , missing expectations by -0.29%.
Dividend declared on 27 Mar 2023
A dividend of $0.27 per share was announced, adjusted to $0.27. The dividend was paid on 30 May 2023.
Earnings released on 21 Feb 2023
EPS came in at $0.20 falling short of the estimated $0.23 by -14.75%, while revenue for the quarter reached $11.46B , missing expectations by -0.27%.
Earnings released on 30 Oct 2022
EPS came in at $0.14 falling short of the estimated $0.17 by -16.67%, while revenue for the quarter reached $10.21B , missing expectations by -1.06%.
Earnings released on 2 Aug 2022
EPS came in at $0.21 surpassing the estimated $0.21 by +0.19%, while revenue for the quarter reached $10.48B , beating expectations by +25.45%.
Dividend declared on 16 May 2022
A dividend of $0.24 per share was announced, adjusted to $0.26. The dividend was paid on 21 Jun 2022.
Earnings released on 4 May 2022
EPS came in at $0.23 surpassing the estimated $0.21 by +7.48%, while revenue for the quarter reached $10.75B , beating expectations by +4.36%.
Earnings released on 22 Feb 2022
EPS came in at $0.27 surpassing the estimated $0.26 by +5.35%, while revenue for the quarter reached $11.30B , beating expectations by +0.39%.
Earnings released on 2 Nov 2021
EPS came in at $0.22 , while revenue for the quarter reached $10.82B .
Earnings released on 30 Jul 2021
EPS came in at $0.26 , while revenue for the quarter reached $10.97B .
Dividend declared on 19 May 2021
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 3 Jun 2021.
Earnings released on 6 May 2021
EPS came in at $0.24 , while revenue for the quarter reached $10.57B .
Earnings released on 23 Feb 2021
EPS came in at $0.26 , while revenue for the quarter reached $11.41B .
Earnings released on 29 Oct 2020
EPS came in at $0.22 , while revenue for the quarter reached $10.47B .
FSNUY Stock Performance
Access detailed FSNUY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.